Lacosamide as the first add-on therapy in adult patients with focal epilepsy: A multicenter real-world study

Lacosamide as the first add-on therapy in adult patients with focal epilepsy: A multicenter real-world study

BackgroundProspective observations on the effectiveness, safety, tolerance, and influence of comorbidity of add-on lacosamide (LCM) therapy are still lacking, especially for domestic generic LCM in China.ObjectiveIn this multicenter real-world study, we aimed to evaluate lacosamide (LCM) as the firs...

Full description

Bibliographic Details
Main Authors: Wenyu Liu, Wenjing Li, Peiyu Wang, Hesheng Zhang, Enhui Zhang, Xintong Wu, Dong Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Neurology
Subjects:
focal epilepsy
lacosamide
adult
efficacy
add-on therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1136814/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2023.1136814/full

Similar Items